Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tea Lund Laursen, Anders Mellemkjær, Holger Jon Møller, Henning Grønbæk & Konstantin Kazankov. (2022) Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 26:8, pages 697-705.
Read now
Read now
Carminda Goersch Lamboglia, Ashley P. Mccurdy, Yeong-Bae Kim, Cliff Lindeman, Amie J. Mangan, Allison Sivak, Diana Mager & John C. Spence. (2022) Investigation of movement-related behaviors and energy compensation in people living with liver disease: A scoping review. Journal of Sports Sciences 40:12, pages 1299-1307.
Read now
Read now
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov & Henning Grønbæk. (2021) Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?. Expert Review of Gastroenterology & Hepatology 15:1, pages 51-64.
Read now
Read now
Markus Niemelä, Onni Niemelä, Risto Bloigu, Aini Bloigu, Päivikki Kangastupa & Tatu Juvonen. (2020) Serum Calprotectin, a Marker of Neutrophil Activation, and Other Mediators of Inflammation in Response to Various Types of Extreme Physical Exertion in Healthy Volunteers. Journal of Inflammation Research 13, pages 223-231.
Read now
Read now
Articles from other publishers (21)
Julia Lischka:Andrea Schanzer, Charlotte de Gier, Susanne Greber-Platzer & Maximilian Zeyda. (2023) Macrophage-associated markers of metaflammation are linked to metabolic dysfunction in pediatric obesity. Cytokine 171, pages 156372.
Crossref
Crossref
Miwa Kawanaka, Ken Nishino, Mayuko Kawada, Katsunori Ishii, Tomohiro Tanikawa, Ryo Katsumata, Noriyo Urata, Jun Nakamura, Mitsuhiko Suehiro, Ken Haruma & Hirofumi Kawamoto. (2023) Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis. BMC Gastroenterology 23:1.
Crossref
Crossref
Irineu O. M. Callegari, Guilherme Z. Rocha & Alexandre G. Oliveira. (2023) Physical exercise, health, and disease treatment: The role of macrophages. Frontiers in Physiology 14.
Crossref
Crossref
Maria Kløjgaard Skytthe, Felix Boel Pedersen, Charlotte Wilhelmina Wernberg, Vineesh Indira Chandran, Aleksander Krag, Tina Di Caterino, Samuel Coelho Mandacaru, Blagoy Blagoev, Mette Munk Lauridsen, Sönke Detlefsen, Jonas Heilskov Graversen & Søren Kragh Moestrup. (2023) Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163. Gastro Hep Advances 2:5, pages 711-720.
Crossref
Crossref
Magdalene Ameka & Alyssa H. Hasty. 2011. Comprehensive Physiology. Comprehensive Physiology
3641
3663
.
Tea Lund Laursen, Mikkel Breinholt Kjær, Louise Kristensen & Henning Grønbæk. (2022) Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center. Journal of Clinical Medicine 11:9, pages 2271.
Crossref
Crossref
Konstantin Kazankov, Kirstine Nyvold Bojsen‐Møller, Holger Jon Møller, Sten Madsbad & Henning Grønbæk. (2022) Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass. Physiological Reports 10:2.
Crossref
Crossref
Chunye Zhang, Shuai Liu & Ming Yang. (2021) Functions of two distinct Kupffer cells in the liver. Exploration of Medicine, pages 511-515.
Crossref
Crossref
Hayam El Aggan, Sabah Mahmoud, Heba El Shair & Hazem Elabd. (2021) Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients. Biomedical Journal 44:6, pages S179-S189.
Crossref
Crossref
Rocío Gallego-Durán, Rocío Montero-Vallejo, Douglas Maya-Miles, Ana Lucena, Franz Martin, Javier Ampuero & Manuel Romero-Gómez. (2021) Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe & Lindsey Devisscher. (2021) The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 10:11, pages 2959.
Crossref
Crossref
Ulla Nivukoski, Aini Bloigu, Risto Bloigu, Johanna Kultti, Heidi Tuomi & Onni Niemelä. (2021) Comparison of serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to alcohol consumption. Alcohol 95, pages 45-50.
Crossref
Crossref
Joeri Lambrecht & Frank Tacke. (2021) Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Frontiers in Immunology 11.
Crossref
Crossref
Rasmus Hvidbjerg Gantzel, Mikkel Breinholt Kjær, Tea Lund Laursen, Konstantin Kazankov, Jacob George, Holger Jon Møller & Henning Grønbæk. (2021) Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis. Frontiers in Medicine 7.
Crossref
Crossref
João P. Magalhães, Diana A. Santos, Inês R. Correia, Megan Hetherington-Rauth, Rogério Ribeiro, João F. Raposo, Andreia Matos, Manuel D. Bicho & Luís B. Sardinha. (2020) Impact of combined training with different exercise intensities on inflammatory and lipid markers in type 2 diabetes: a secondary analysis from a 1-year randomized controlled trial. Cardiovascular Diabetology 19:1.
Crossref
Crossref
Marlene Christina Nielsen, Rasmus Hvidbjerg Gantzel, Joan Clària, Jonel Trebicka, Holger Jon Møller & Henning Grønbæk. (2020) Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure. Cells 9:5, pages 1175.
Crossref
Crossref
Chiara Rosso, Konstantin Kazankov, Ramy Younes, Saeed Esmaili, Milena Marietti, Marco Sacco, Fabrizia Carli, Melania Gaggini, Federico Salomone, Holger Jon Møller, Maria Lorena Abate, Hendrik Vilstrup, Amalia Gastaldelli, Jacob George, Henning Grønbæk & Elisabetta Bugianesi. (2019) Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. Journal of Hepatology 71:5, pages 1012-1021.
Crossref
Crossref
Tzu-Yu Hu, Shin-Yng Lee, Chun-Kuang Shih, Meng-Jung Chou, Meng-Chieh Wu, I-Chun Teng, Chyi-Huey Bai, Nindy Sabrina, Alexey A. Tinkov, Anatoly V. Skalny & Jung-Su Chang. (2019) Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome. Nutrients 11:4, pages 940.
Crossref
Crossref
Elisabeth De Smit, Samuel W. Lukowski, Lisa Anderson, Anne Senabouth, Kaisar Dauyey, Sharon Song, Bruce Wyse, Lawrie Wheeler, Christine Y. Chen, Khoa Cao, Amy Wong Ten Yuen, Neil Shuey, Linda Clarke, Isabel Lopez Sanchez, Sandy S. C. Hung, Alice Pébay, David A. Mackey, Matthew A. Brown, Alex W. Hewitt & Joseph E. Powell. (2018) Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis. BMC Medical Genomics 11:1.
Crossref
Crossref
Sung-Hui Tseng, Ting-Yun Chang, Chun-Kuang Shih, Rong-Hong Hsieh, Chia-Wen Chen, Yi-Chun Chen, Mei-Hsiang Lin & Jung-Su Chang. (2018) Effect of Endoplasmic Reticular Stress on Free Hemoglobin Metabolism and Liver Injury. International Journal of Molecular Sciences 19:7, pages 1977.
Crossref
Crossref
Peter Lykke Eriksen, Karen Louise Thomsen, Tea Lund Laursen, Konstantin Kazankov, Sara Heebøll & Henning Grønbæk. (2017) Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD. Current Hepatology Reports 16:4, pages 308-316.
Crossref
Crossref